Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03173950 |
| Title | Immune Checkpoint Inhibitor Nivolumab in People With Select Rare CNS Cancers |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | National Cancer Institute (NCI) |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Northwestern University | RECRUITING | Chicago | Illinois | 60611 | United States | Details |
| National Institutes of Health Clinical Center | RECRUITING | Bethesda | Maryland | 20892 | United States | Details |
| UT MD Anderson Cancer Center | RECRUITING | Houston | Texas | 77030-4096 | United States | Details |